Literature DB >> 28149017

Malabsorption, Orocecal Transit Time and Small Intestinal Bacterial Overgrowth in Type 2 Diabetic Patients: A Connection.

S V Rana1, Aastha Malik1, Sanjay K Bhadada2, Naresh Sachdeva2, Rajesh Kumar Morya1, Gaurav Sharma1.   

Abstract

Type 2 diabetes mellitus consists of dysfunctions characterized by hyperglycemia and resulting from combination of resistance to insulin action and inadequate insulin secretion. Most of diabetic patients report significant gastrointestinal symptoms. Entire GI tract can be affected by diabetes from oral cavity to large bowel and anorectal region. Proteins, carbohydrates, fats, and most fluids are absorbed in small intestine. Malabsorption may occurs when proper absorption of nutrients does not take place due to bacterial overgrowth or altered gut motility. The present study was planned to measure various malabsorption parameters in type 2 diabetic patients. 175 patients and 175 age and sex matched healthy controls attending Endocrinology Clinic in PGI, Chandigarh were enrolled. Lactose intolerance was measured by using non-invasive lactose hydrogen breath test. Urinary d-xylose and fecal fat were estimated using standard methods. Orocecal transit time and small intestinal bacterial overgrowth were measured using non-invasive lactulose and glucose breath test respectively. Out of 175 diabetic patients enrolled, 87 were males while among 175 healthy subjects 88 were males. SIBO was observed in 14.8 % type 2 diabetic patients and in 2.8 % of controls. There was statistically significant increase (p < 0.002) in OCTT in type 2 diabetic patients compared with controls. OCTT was observed to be more delayed (p < 0.003) in patients who were found to have SIBO than in patients without SIBO. Lactose intolerance was observed in 60 % diabetic patients and 39.4 % in controls. Urinary d-xylose levels were also lower in case of diabetic patients but no significant difference was found in 72 h fecal fat excretion among diabetic patients and controls. Urinary d-xylose and lactose intolerance in SIBO positive type 2 diabetic patients was more severe as compared to SIBO negative diabetic patients. From this study we can conclude that delayed OCTT may have led to SIBO which may have instigated the process of malabsorption among type 2 diabetic patients.

Entities:  

Keywords:  Lactose intolerance; Orocecal transit time; Small intestinal bacterial overgrowth; Type 2 diabetic patients; Urinary d-xylose

Year:  2016        PMID: 28149017      PMCID: PMC5247367          DOI: 10.1007/s12291-016-0569-6

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  19 in total

1.  Effects of duodenal distension on antropyloroduodenal pressures and perception are modified by hyperglycemia.

Authors:  T Lingenfelser; W Sun; G S Hebbard; J Dent; M Horowitz
Journal:  Am J Physiol       Date:  1999-03

2.  Small-bowel bacterial overgrowth in diabetic subjects is associated with cardiovascular autonomic neuropathy.

Authors:  B Zietz; G Lock; R H Straub; B Braun; J Schölmerich; K D Palitzsch
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

3.  The influence of induced hyperglycaemia on the characteristics of intestinal motility and bile kinetics in healthy men.

Authors:  E Oster-Jørgensen; N Qvist; S A Pedersen; L Rasmussen; C P Hovendal
Journal:  Scand J Gastroenterol       Date:  1992-04       Impact factor: 2.423

4.  India--diabetes capital of the world: now heading towards hypertension.

Authors:  Shashank R Joshi; Rakesh M Parikh
Journal:  J Assoc Physicians India       Date:  2007-05

5.  The effect of acute hyperglycaemia on small intestinal motility in normal subjects.

Authors:  A Russo; R Fraser; M Horowitz
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

Review 6.  Relationships of upper gastrointestinal motor and sensory function with glycemic control.

Authors:  C K Rayner; M Samsom; K L Jones; M Horowitz
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

7.  Lactose hydrogen breath test in Giardia lamblia-positive patients.

Authors:  S V Rana; D K Bhasin; V K Vinayak
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

8.  Orocecal transit time in patients in the chronic phase of corrosive injury.

Authors:  S V Rana; R Kochhar; R Pal; B Nagi; K Singh
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

9.  Effects of hyperglycemia on interdigestive gastrointestinal motility in humans.

Authors:  E S Björnsson; V Urbanavicius; B Eliasson; S Attvall; U Smith; H Abrahamsson
Journal:  Scand J Gastroenterol       Date:  1994-12       Impact factor: 2.423

Review 10.  The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes.

Authors:  R M Anjana; M K Ali; R Pradeepa; M Deepa; M Datta; R Unnikrishnan; M Rema; V Mohan
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

View more
  10 in total

Review 1.  Diabetes and the Small Intestine.

Authors:  Jonathan Gotfried; Stephen Priest; Ron Schey
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

2.  Small Intestine Bacterial Overgrowth Can Form an Indigenous Proinflammatory Environment in the Duodenum: A Prospective Study.

Authors:  Evripidis Rizos; Emmanouel Pyleris; Mark Pimentel; Konstantinos Triantafyllou; Evangelos J Giamarellos-Bourboulis
Journal:  Microorganisms       Date:  2022-05-02

Review 3.  The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders.

Authors:  Giuseppe Losurdo; Fulvio Salvatore D'Abramo; Giuseppe Indellicati; Chiara Lillo; Enzo Ierardi; Alfredo Di Leo
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

4.  Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression.

Authors:  Bara El Kurdi; Sumbal Babar; Mahmoud El Iskandarani; Adam Bataineh; Markus M Lerch; Mark Young; Vijay P Singh
Journal:  Clin Transl Gastroenterol       Date:  2019-09       Impact factor: 4.488

Review 5.  The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions.

Authors:  Arthur J Kastl; Natalie A Terry; Gary D Wu; Lindsey G Albenberg
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-07-22

6.  Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis.

Authors:  Giuseppe Losurdo; Gioacchino Leandro; Enzo Ierardi; Francesco Perri; Michele Barone; Mariabeatrice Principi; Alfredo Di Leo
Journal:  J Neurogastroenterol Motil       Date:  2020-01-30       Impact factor: 4.924

7.  The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis.

Authors:  Xin Feng; Xiao-Qing Li
Journal:  Aging (Albany NY)       Date:  2022-01-27       Impact factor: 5.682

8.  Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association.

Authors:  Uday C Ghoshal; Sanjeev Sachdeva; Ujjala Ghoshal; Asha Misra; Amarender Singh Puri; Nitesh Pratap; Ayesha Shah; M Masudur Rahman; Kok Ann Gwee; Victoria P Y Tan; Tahmeed Ahmed; Yeong Yeh Lee; B S Ramakrishna; Rupjyoti Talukdar; S V Rana; Saroj K Sinha; Minhu Chen; Nayoung Kim; Gerald Holtmann
Journal:  Indian J Gastroenterol       Date:  2022-10-10

9.  Delayed Gastric Emptying Is Not Associated with a Microbiological Diagnosis of Small Intestinal Bacterial Overgrowth.

Authors:  Gerardo Calderon; Robert M Siwiec; Matthew E Bohm; Thomas V Nowak; John M Wo; Anita Gupta; Huiping Xu; Andrea Shin
Journal:  Dig Dis Sci       Date:  2020-03-02       Impact factor: 3.199

10.  Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes.

Authors:  Li-Hui Yan; Biao Mu; Da Pan; Ya-Nan Shi; Ji-Hong Yuan; Yue Guan; Wang Li; Xiao-Yi Zhu; Lei Guo
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.